Multimeric adiponectin nanoparticles regulate glucose metabolism by activating phosphatidylinositol-3-kinase, protein kinase B and T-cadherin

Jiakun Dai,Hongli Shi,Chao Zhang,Bo Li,Yan Li,Yahui Wei
DOI: https://doi.org/10.1016/j.procbio.2022.12.034
IF: 4.885
2023-01-02
Process Biochemistry
Abstract:Adiponectin (AP), especially its multimeric form, is closely related to diabetes, obesity, cardiovascular disease and cancer and plays a positive role in maintaining metabolic homeostasis. In this study, we designed and prepared nanoparticles anchored with AP to mimic multimeric AP. Due to the hydrophobic interaction of the polyhydroxyalkanoate granule binding protein (PhaP) region in the tail of the protein, the AP monomer can be anchored to the surface of poly (lactic-co-glycolic acid) (PLGA) / polyhydroxybutyrate (PHB) nanoparticles during incubation, thus mimicking multimeric AP. Similar to previous studies on the natural multimeric form of AP, the multimeric AP mimetic nanoparticles can upregulate NF-κB and have no obvious effect on AMPK in muscle or endothelial cells. Meanwhile, the nanoparticles showed different activities compared to AP monomer on the cell cycle of MCF7 breast cancer cells. Further studies showed that the multimeric AP nanoparticles can activate PI3K, AKT and the multimeric AP receptor T-cadherin, thereby reducing blood glucose and serum glycoprotein levels in ob/ob mice. Due to the ability to regulate glucose metabolism, it may provide a meaningful strategy for regulating blood glucose levels in diabetes or obesity.
biochemistry & molecular biology,biotechnology & applied microbiology,engineering, chemical
What problem does this paper attempt to address?